clonazepam has been researched along with levodopa in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (18.75) | 18.7374 |
| 1990's | 9 (28.13) | 18.2507 |
| 2000's | 13 (40.63) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Binder, H; Gerstenbrand, F; Hengl, W; Rumpl, E | 1 |
| Goetz, C; Klawans, HL; Nausleda, PA; Weiner, WJ | 1 |
| Lapierre, O; Montplaisir, J; Pelletier, G; Warnes, H | 1 |
| Lang, AE | 1 |
| Marsden, CD; Obeso, JA; Rothwell, JC | 1 |
| Herbster, G; Koller, WC | 1 |
| Ortiz, A | 1 |
| Lunn, V; Northcott, C; Yatham, LN | 1 |
| Maruyama, S; Osawa, M | 1 |
| Hirose, K; Isozaki, E; Miyamoto, K; Noda, K; Oda, M; Tanabe, H | 1 |
| Bakke, SJ; Nyberg-Hansen, R; Shepherd, GM; Tauböll, E | 1 |
| Chang, HC; Chen, RS; Liao, KK; Lu, CS; Tsai, CH | 1 |
| Nozawa, T | 1 |
| Chokroverty, S; Masdeu, JC; Sander, HW; Tavoulareas, G; Walters, A; Zimmerman, T | 1 |
| Jönsson, R; Lindberg, E; Mallon, L; Nyström, B; Ulfberg, J | 1 |
| Apartis, E; Arné, P; Jedynak, CP; Tison, F; Vidailhet, M | 1 |
| Dhanuka, AK; Singh, G | 1 |
| Kachi, T | 1 |
| Gadkary, CA; Mummaneni, PV; Quinones-Hinojosa, A; Rosenberg, WS | 1 |
| Bassetti, CL; Clavadetscher, SC; Gugger, M | 1 |
| Apaydin, H; Kiliç, E; Ozekmekçi, S | 1 |
| Poryazova, RG; Zachariev, ZI | 1 |
| Molnar, MZ; Mucsi, I; Novak, M | 1 |
| Goldstein, R; Klein, C; Miniovitz, A; Pollak, L; Prokhorov, T; Rabey, JM; Shpirer, I; Theitler, J | 1 |
| Allen, RP; Hening, W; Tenzer, P; Winkelman, JW | 1 |
| Bozi, M; Christodoulou, C; Douzenis, A; Gasparinatos, G; Stamboulis, E; Stefanis, C; Stefanis, L; Stefanis, N | 1 |
| Canepa, C | 1 |
| Coleman-Jackson, R; Hershey, LA | 1 |
| Bachoud-Lévi, AC; Blasco-Amaro, JA; Capuano, A; Isabel-Gómez, R; Martín-Gómez, C; Nou-Fontanet, L; Ortigoza-Escobar, JD; Zorzi, G | 1 |
11 review(s) available for clonazepam and levodopa
| Article | Year |
|---|---|
The treatment of the restless leg syndrome with or without periodic leg movements in sleep.
Topics: Anti-Anxiety Agents; Clonazepam; Dextropropoxyphene; Dopamine Agents; Humans; Levodopa; Narcotics; Polysomnography; Restless Legs Syndrome; Sleep Stages; Sleep Wake Disorders | 1992 |
Somatosensory evoked potentials in myoclonus.
Topics: Brain Diseases, Metabolic; Cerebral Cortex; Clonazepam; Electroencephalography; Electromyography; Evoked Potentials, Somatosensory; Humans; Levodopa; Myoclonus; Parkinson Disease; Pyramidal Tracts | 1986 |
[Movement disorders in HTLV-I associated myelopathy (HAM)].
Topics: Clonazepam; Diagnosis, Differential; Electromyography; Humans; Levodopa; Myoclonus; Paraparesis, Tropical Spastic; Polysomnography; Spinal Cord | 1993 |
[Periodic limb movement disorder].
Topics: Anticonvulsants; Clonazepam; Diagnosis, Differential; Dopamine Agents; Humans; Levodopa; Movement Disorders; Periodicity; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders | 1998 |
[Restless legs. A much neglected syndrome].
Topics: Adolescent; Adult; Anticonvulsants; Clonazepam; Dopamine Agents; Humans; Levodopa; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders; Terminology as Topic | 1999 |
[Medical treatment of dystonia].
Topics: Cholinergic Antagonists; Clonazepam; Diazepam; Dopamine Antagonists; Dystonia; Humans; Levodopa; Torticollis; Trihexyphenidyl | 2001 |
REM sleep behavior disorder in patients with Parkinson's disease.
Topics: Anticonvulsants; Antiparkinson Agents; Clonazepam; Humans; Levodopa; Parkinson Disease; Polysomnography; REM Sleep Behavior Disorder | 2005 |
Management of restless legs syndrome in patients on dialysis.
Topics: Amines; Anticonvulsants; Benzothiazoles; Clonazepam; Cyclohexanecarboxylic Acids; Dopamine Agents; Gabapentin; gamma-Aminobutyric Acid; Humans; Kidney Failure, Chronic; Levodopa; Narcotics; Pramipexole; Renal Dialysis; Restless Legs Syndrome; Thiazoles; Uremia | 2006 |
Restless legs syndrome: nonpharmacologic and pharmacologic treatments.
Topics: Amines; Anemia, Iron-Deficiency; Anticonvulsants; Benzothiazoles; Clonazepam; Cyclohexanecarboxylic Acids; Dopamine Agents; Dopamine Agonists; Ferritins; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Iron; Levodopa; Pramipexole; Restless Legs Syndrome; Trace Elements | 2007 |
Pharmacological Management of Dementia with Lewy Bodies.
Topics: Age Factors; Aged; Anticonvulsants; Antiparkinson Agents; Cholinesterase Inhibitors; Clinical Trials, Phase II as Topic; Clonazepam; Humans; Levodopa; Lewy Body Disease; Melatonin; Randomized Controlled Trials as Topic; Zonisamide | 2019 |
Systematic review of drug therapy for chorea in NXK2-1-related disorders: Efficacy and safety evidence from case studies and series.
Topics: Carbidopa; Chorea; Clonazepam; Humans; Levodopa; Methylphenidate; Tetrabenazine | 2023 |
1 trial(s) available for clonazepam and levodopa
| Article | Year |
|---|---|
Adjuvant therapy of parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Carbidopa; Clonazepam; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Primidone; Propranolol; Random Allocation; Tremor; Trihexyphenidyl | 1987 |
20 other study(ies) available for clonazepam and levodopa
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
[Electrophysiogical and neuropharmacological studies in a patient with progressive myoclonus-epilepsy (author's transl)].
Topics: Adult; Anticonvulsants; Brain; Clonazepam; Diazepam; Electroencephalography; Epilepsies, Myoclonic; Female; Humans; Levodopa; Phenobarbital; Taurine | 1977 |
Clonazepam and dopamine-related stereotyped behavior.
Topics: Animals; Apomorphine; Behavior; Benzodiazepinones; Clonazepam; Dopamine; Drug Interactions; Ergot Alkaloids; Guinea Pigs; Humans; Levodopa; Male; Stereotyped Behavior; Time Factors | 1977 |
Restless legs syndrome and Parkinson's disease: insights into pathophysiology.
Topics: Aged; Clonazepam; Codeine; Dopamine; Humans; Levodopa; Male; Parkinson Disease; Restless Legs Syndrome | 1987 |
Neuropharmacological profile of Meige's disease: overview and a case report.
Topics: Aged; Baclofen; Benztropine; Clonazepam; Doxepin; Drug Therapy, Combination; Dystonia; Facial Muscles; Haloperidol; Humans; Levodopa; Male; Spasm | 1983 |
Parkinsonism and bipolar affective disorder.
Topics: Aged; Antiparkinson Agents; Bipolar Disorder; Carbidopa; Clonazepam; Dopamine; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Lithium Carbonate; Male; Parkinson Disease, Secondary | 1995 |
[Rhythmical involuntary movement at rest associated with olivo-ponto-cerebellar atrophy (OPCA)].
Topics: Adolescent; Aged; Brain; Clonazepam; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Olivopontocerebellar Atrophies; Parkinson Disease; Rest; Trihexyphenidyl | 1993 |
Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Antiparkinson Agents; Cerebral Hemorrhage; Clonazepam; Electric Stimulation; Electrodes, Implanted; Humans; Hypertrophy; Levodopa; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Nerve Degeneration; Neural Pathways; Olivary Nucleus; Pons; Propranolol; Thalamus; Tremor | 1997 |
Acanthocytosis and spinocerebellar degeneration: a new association?
Topics: Acanthocytes; Adult; Anticonvulsants; Antiparkinson Agents; Carbidopa; Cerebellum; Clonazepam; Drug Therapy, Combination; Humans; Levodopa; Magnetic Resonance Imaging; Male; Spinocerebellar Degenerations; Videotape Recording; Vitamin E | 1997 |
Orthostatic tremor: an electrophysiological analysis.
Topics: Aged; Antiparkinson Agents; Carbidopa; Central Nervous System Diseases; Clonazepam; Drug Combinations; Electroencephalography; Electromyography; Evoked Potentials; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Neurons; Muscle, Skeletal; Neural Conduction; Posture; Treatment Outcome; Tremor | 1998 |
Fast orthostatic tremor in Parkinson's disease mimicking primary orthostatic tremor.
Topics: Aged; Anti-Anxiety Agents; Antiparkinson Agents; Clonazepam; Electromyography; Female; Humans; Leg; Levodopa; Male; Parkinson Disease; Treatment Outcome; Tremor | 2001 |
Periodic limb movement disorder : a clinical and polysomnographic study.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Carbidopa; Clonazepam; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Polysomnography; Retreatment | 2001 |
Split spinal cord malformation in an elderly patient: case report.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Carbidopa; Clonazepam; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Low Back Pain; Magnetic Resonance Imaging; Movement Disorders; Spinal Dysraphism; Tomography, X-Ray Computed | 2004 |
Restless legs syndrome: clinical experience with long-term treatment.
Topics: Adult; Aged; Amines; Clonazepam; Cyclohexanecarboxylic Acids; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Narcotics; Prospective Studies; Restless Legs Syndrome; Treatment Outcome | 2004 |
Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.
Topics: Age Factors; Aged; Antiparkinson Agents; Case-Control Studies; Clonazepam; Dyskinesias; Female; GABA Modulators; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; REM Sleep Behavior Disorder; Severity of Illness Index | 2005 |
Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzodiazepines; Clonazepam; Cohort Studies; Comorbidity; Disorders of Excessive Somnolence; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Reference Values; Restless Legs Syndrome; Sleep Stages; Wakefulness | 2006 |
Isolated delusional syndrome in Parkinson's Disease.
Topics: Aged; Amantadine; Antiparkinson Agents; Benserazide; Benzothiazoles; Catechols; Clonazepam; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Pramipexole; Schizophrenia, Paranoid; Syndrome | 2010 |
Park sleep: a non-motor dominant Parkinson's disease phenotype.
Topics: Aged; Clonazepam; Humans; Levodopa; Male; Parkinson Disease; REM Sleep Behavior Disorder | 2016 |